|
|
Volumn 383, Issue 9930, 2014, Pages 1694-
|
|
Management of liver cirrhosis
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
NEW DRUG;
SIMEPREVIR;
SOFOSBUVIR;
ALCOHOL USE DISORDER;
CAUSE OF DEATH;
DEVELOPED COUNTRY;
DRUG COST;
EDITORIAL;
HEALTH CARE QUALITY;
HEPATITIS B;
HEPATITIS B VIRUS;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
LIVER CELL CARCINOMA;
LIVER CIRRHOSIS;
MORBIDITY;
MORTALITY;
NONALCOHOLIC FATTY LIVER;
NONHUMAN;
PRACTICE GUIDELINE;
PREVALENCE;
PRIORITY JOURNAL;
SCALE UP;
SOUTH ASIA;
ALCOHOLISM;
DRUG APPROVAL;
EUROPEAN MEDICINES AGENCY;
FOOD AND DRUG ADMINISTRATION;
SCREENING;
ANTIVIRAL AGENTS;
HEPATITIS C;
HUMANS;
LIVER CIRRHOSIS;
|
|
EID: 84900561913
PISSN: 01406736
EISSN: 1474547X
Source Type: Journal
DOI: 10.1016/S0140-6736(14)60815-1 Document Type: Editorial |
|
Times cited : (4)
|
|
References (0)
|